Rocket Pharmaceuticals Ownership | Who Owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals Ownership Summary

Rocket Pharmaceuticals is owned by 23.93% institutional investors, 2.95% insiders, and 73.12% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 15.92% of RCKT shares. Vanguard Health Care Inv is the top mutual fund, with 7.11% of its assets in Rocket Pharmaceuticals shares.

RCKT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Rocket Pharmaceuticals	23.93%	2.95%	73.12%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rtw investments, lp	17.69M	15.92%	$63.32M
Vanguard group	8.54M	7.66%	$29.99M
Blackrock funding, inc. /de	7.83M	7.05%	$28.05M
Blackrock	6.19M	6.61%	$133.33M
Citigroup	5.11M	4.60%	$18.29M
Janus henderson group	4.00M	4.25%	$50.34M
State street	4.49M	4.04%	$16.06M
Maverick capital	3.57M	3.21%	$12.77M
Newtyn management	3.17M	2.85%	$11.33M
Nuveen	3.13M	2.82%	$11.20M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	150.71K	2.53%	$1.89M
Lion point capital, lp	86.00K	1.84%	$307.88K
Boxer capital	1.47M	1.66%	$31.56M
M28 capital management lp	210.87K	1.40%	$754.92K
Monaco asset management sam	2.06M	1.36%	$7.37M
Newtyn management	3.17M	1.21%	$11.33M
Amitell capital pte	178.77K	1.03%	$639.99K
Velan capital investment management lp	294.64K	0.66%	$1.05M
Cowen and company	1.10M	0.65%	$23.68M
Rtw investments, lp	17.69M	0.63%	$63.32M

Top Buyers

Holder	Shares	% Assets	Change
Marshall wace, llp	3.04M	0.01%	3.01M
Nuveen	3.13M	0.00%	2.97M
State street	4.49M	0.00%	2.79M
Aqr capital management	3.07M	0.01%	2.37M
Janus henderson group	4.00M	0.03%	2.11M

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	-	-	-12.63M
Westfield capital management co lp	-	-	-4.82M
Suvretta capital management	-	-	-2.99M
Morgan stanley	2.02M	0.00%	-1.92M
Bioimpact capital	-	-	-1.59M

New Positions

Holder	Shares	% Assets	Change	Value
Abrdn	664.82K	0.00%	664.82K	$2.38M
Woodline partners lp	641.22K	0.01%	641.22K	$2.30M
Vanguard fiduciary trust	590.75K	0.00%	590.75K	$2.11M
Jacobs levy equity management	416.53K	0.01%	416.53K	$1.49M
Velan capital investment management lp	294.64K	0.66%	294.64K	$1.05M

Sold Out

Holder	Change
Clearstead advisors	-14.00
Smartleaf asset management	-20.00
Wealthspire advisors	-20.00
Allspring global investments	-20.00
First horizon advisors	-24.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	84	-54.35%	26,596,215	-70.86%	23	0.36%	51	-41.38%	21	-70.83%
Dec 31, 2025	114	-37.36%	46,937,731	-51.45%	42	0.55%	55	-40.86%	41	-31.67%
Sep 30, 2025	152	-22.84%	69,915,346	-20.60%	62	1.00%	73	-38.66%	55	27.91%
Jun 30, 2025	204	-17.07%	94,897,210	-11.80%	85	0.89%	123	-23.13%	44	2.33%
Mar 31, 2025	246	5.58%	107,782,550	-1.70%	97	0.72%	160	4.58%	43	-6.52%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	7.60M	7.11%	-
State Street® SPDR® S&P® Biotech ETF	2.83M	2.60%	-29.25K
Vanguard Total Stock Mkt Idx Inv	2.70M	2.47%	-
RTW Biotech Opportunities Ord	2.57M	2.37%	170.76K
Vanguard US Total Market Shares ETF	2.21M	2.08%	-245.50K
iShares Russell 2000 ETF	1.99M	1.82%	16.78K
SPDR® S&P Biotech ETF	1.79M	1.66%	10.61K
Nuveen Quant Small Cap Equity R6	1.72M	1.57%	1.72M
Westfield Capital Mgt Co Sm-Cap Gr Eq	1.23M	1.16%	22.76K
Harbor Small Cap Growth Instl	1.23M	1.14%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 21, 2026	Shah Gaurav	CEO	Sell	$171.84K
May 19, 2026	Shah Gaurav	CEO	Sell	$7.26K
May 19, 2026	Wilson Martin	General Counsel	Sell	$2.00K
May 19, 2026	Militello John	See Remarks	Sell	$1.16K
May 13, 2026	Wilson Martin	General Counsel	Sell	$12.12K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	8
2026 Q1	1	6
2025 Q4	-	8
2025 Q3	1	10
2025 Q2	2	12

RCKT Ownership FAQ

Who Owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals shareholders are primarily institutional investors at 23.93%, followed by 2.95% insiders and 73.12% retail investors. The average institutional ownership in Rocket Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Rocket Pharmaceuticals falls below.

Who owns the most shares of Rocket Pharmaceuticals?

Rocket Pharmaceuticals’s largest shareholders are Rtw investments, lp (17.69M shares, 15.92%), Vanguard group (8.54M shares, 7.66%), and Blackrock funding, inc. /de (7.83M shares, 7.05%). Together, they hold 30.63% of Rocket Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rocket Pharmaceuticals?

Yes, BlackRock owns 6.61% of Rocket Pharmaceuticals, totaling 6.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 133.33M$. In the last quarter, BlackRock increased its holdings by 262.72K shares, a 4.43% change.

Who is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.53% of its assets in 150.71K Rocket Pharmaceuticals shares, valued at 1.89M$.

Who is the top mutual fund holder of Rocket Pharmaceuticals shares?

Vanguard Health Care Inv is the top mutual fund holder of Rocket Pharmaceuticals shares, with 7.11% of its total shares outstanding invested in 7.6M Rocket Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools